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Cystathionine -synthase (CBS) deficiency causes se-
vere hyperhomocysteinemia and other signs of homo-
cystinuria syndrome, in particular a premature athero-
sclerosis with multiple thrombosis. However, the
molecular mechanisms by which homocysteine could in-
terfere with normal cell function are poorly understood
in a whole organ like the liver, which is central to the
catabolism of homocysteine. We used a combination of
differential display and cDNA arrays to analyze differ-
ential gene expression in association with elevated he-
patic homocysteine levels in CBS-deficient mice, a mu-
rine model of hyperhomocysteinemia. Expression of
several genes was found to be reproducibly abnormal in
the livers of heterozygous and homozygous CBS-defi-
cient mice. We report altered expression of genes encod-
ing ribosomal protein S3a and methylthioadenosine
phosphorylase, suggesting such cellular growth and
proliferation perturbations may occur in homozygous
CBS-deficient mice liver. Many up- or down-regulated
genes encoded cytochromes P450, evidence of perturba-
tions of the redox potential in heterozygous and ho-
mozygous CBS-deficient mice liver. The expression of
various genes involved in severe oxidative processes
was also abnormal in homozygous CBS-deficient mice
liver. Among them, the expression of heme oxygenase 1
gene was increased, concomitant with overexpression of
heme oxygenase 1 at the protein level. Commensurate
with the difference in hepatic mRNA paraoxonase 1
abundance, the mean hepatic activity of paraoxonase 1,
an enzyme that protects low density lipoprotein from
oxidation, was 3-fold lower in homozygous CBS-defi-
cient mice. Heterozygous CBS-deficient mice, when fed
a hyperhomocysteinemic diet, have also reduced PON1
activity, which demonstrates the effect of hyperhomo-
cysteinemia in the paraoxonase 1 activity.
Homocysteine (Hcy)1 is a sulfur-containing amino acid that
is potentially toxic. It is synthesized during the conversion of
dietary methionine to cysteine. Hcy has several possible fates.
It may undergo remethylation to methionine via the folic acid
and B12-dependent enzyme methionine synthase or via the
enzyme betaine homocysteine methyltransferase (1). Alterna-
tively, Hcy can enter the transsulfuration pathway under con-
ditions in which an excess of methionine is present or cysteine
synthesis is required. In this pathway, Hcy first condenses with
serine to form cystathionine in a rate-limiting reaction cata-
lyzed by the B6-dependent enzyme cystathionine -synthase
(CBS), and then cystathionine is used to yield cysteine. Cys-
teine is a major precursor of glutathione, the principal redox
metabolite in the cell.
CBS deficiency, an inborn metabolic defect that displays an
autosomal recessive inheritance, is the most common identifi-
able cause of hyperhomocysteinemia (HH) (2). HH is associated
with an increased incidence of vascular thrombosis and devel-
opment of premature atherosclerosis (3). Severe monogenic HH
(also referred to as homocystinuria) is commonly caused by
mutations in the CBS gene that prevent the use of Hcy in the
biosynthesis of cysteine and lead to abnormally high plasma
total Hcy (tHcy) concentrations in patients with severe HH
(100–250 M). Normal plasma tHcy concentrations range from
5 to 15 M. Mild HH, usually defined as plasma levels of tHcy
between 15 and 30 M, is associated with increased risk of
atherosclerosis (4).
The relationship between high Hcy concentrations in the
blood and thrombosis has been a subject of considerable re-
search. Endothelial dysfunction is a key process in atheroscle-
rosis and has been reported in patients with HH (5) and in
experimental HH, which is induced by methionine loading in
normal subjects (6). Administration of Hcy causes vascular
injury and thrombosis in animals (7). It is thought to predis-
pose to atherosclerosis by injuring the vascular endothelium;
after exposure to Hcy, endothelial dysfunction occurs at several
levels, suggesting that Hcy contributes to enhanced vascular
inflammation and hemostatic changes linked to the develop-
ment of atherosclerosis and a prothrombotic state.
An understanding of these processes at the molecular level is
required to elucidate the mechanism of cell injury by Hcy.
Expression of a range of genes has been shown to be modulated
in cultured human umbilical vein endothelial cells, vascular
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smooth muscle cells, human megakaryocytic cell line (DAMI),
hepatic stellate cells, human hepatoma cell line (HepG2), and
primary neuronal cells exposed to exogenous excess Hcy (8–
16). In vitro, high levels of Hcy affect the expression of the
endoplasmic reticulum stress-response genes, the acute trans-
lational responses genes, mitochondrial genes, genes encoding
antioxidant enzymes and transcription factors, and genes im-
plicated in cell growth, cellular differentiation and prolifera-
tion, and regulation of extracellular matrix homeostasis. Un-
fortunately, most in vitro studies use physiologically irrelevant
concentrations or forms or both of Hcy, concentrations much
higher than those found in patients with HH. Therefore, stud-
ies need to be conducted using a pathophysiologically relevant
model of in vivo HH.
A well characterized genetic model of HH in mice was ob-
tained by targeted deletion of the CBS gene by homologous
recombination (17) and has been used to show the influence of
HH on vascular function (18–22). Homozygous CBS-deficient
mice (CBS / mice) develop very high plasma tHcy concen-
trations, and heterozygous CBS-deficient mice (CBS / mice)
have mildly elevated plasma concentrations of tHcy (17–23).
Both CBS / and CBS / mice exhibit some pathological
features of HH such as endothelial dysfunction (18–22), which
can be negated by overexpression of glutathione peroxidase
(21), and hepatic steatosis (17, 24).
Although the mechanisms that lead to high plasma Hcy have
been well established, the molecular basis of Hcy-mediated
alteration of cellular function in whole organs is not completely
understood. To elucidate the molecular mechanisms responsi-
ble for the interference in normal tissue function, we searched
for genes whose expression is abnormal in CBS-deficient mice.
Impaired liver function has been associated with elevated
plasma levels of tHcy (25–27), evidence of the central role of the
liver in the metabolism of methionine and consequently in the
catabolism of Hcy (28). A recent study shows that the liver is
indeed a key organ in Hcy metabolism and contributes to much
of the plasma Hcy (29). We therefore focused our research on
the liver of CBS-deficient mice and monitored gene expression
by a combination of differential display reverse transcriptase
(RT)-PCR and cDNA expression array analysis. We found that
13 genes were up- or down-regulated in liver from 3- and
4-month-old CBS / and/or CBS / mice. Several of these
genes affected in CBS / mouse liver suggest altered cellular
growth and severe oxidative processes.
EXPERIMENTAL PROCEDURES
Mice and Genotype Determination—The CBS gene in mouse embry-
onic stem cells was inactivated by homologous recombination (17). CBS
/ mice were bred to produce CBS / mice. Tail biopsies were
obtained from mice at 4 weeks of age, and the PCR was used for
genotyping for the targeted CBS allele (17). CBS / mice, CBS /
mice, and wild type control (CBS /) mice from the same litter were
used at three and four months of age. CBS / mice fed a standard
laboratory diet died young. Therefore, CBS /, CBS /, and CBS
/ mice were fed standard A04 rodent chow (Usine d’Alimentation
Rationnelle, Epinay sur Orge, France) supplemented with 1.592 g/kg
choline chloride salt.
Plasma and Hepatic tHcy Assays—At the time of sacrifice, blood
samples were collected in tubes containing a 1⁄10 volume of 3.8% sodium
citrate and placed on ice immediately, and plasma was isolated by
centrifugation at 2500  g for 15 min at 4 °C. Liver was harvested,
snap-frozen, and stored at 80 °C until use. tHcy was assayed in
plasma and crude liver extracts with a fluorescence polarization immu-
noassay using an Abbott IMX analyzer (Abbott Laboratories, Missis-
sauga, Ontario, Canada) (30) and normalized to total protein concen-
tration for liver extracts.
Western Blot Analysis—Total protein liver extracts (20 g) were
subjected to SDS electrophoresis on 12% gels under reducing conditions
by the method of Laemmli (31). Proteins were transferred electro-
phoretically to nitrocellulose membranes (Bio-Rad). The membranes
were blocked with Tris buffer (1.5 mM Tris base, pH 8, 5 mM NaCl, 0.1%
Tween 20) containing 5% skimmed milk, and the immobilized proteins
were immunostained with a polyclonal antibody directed against rat
CBS (1:10000 dilution) (32) or with anti-Cu,Zn superoxide dismutase 1
(SOD1) (1:1000 dilution) (Calbiochem) or with anti-HO-1 (1:200 dilu-
tion) (Sigma-Aldrich), or with anti--tubulin (1:2000 dilution) (Sigma-
Aldrich). After incubation with the primary and peroxidase-conjugated
secondary antibodies, blots were developed with the enhanced chemi-
luminescence reagent (Amersham Biosciences).
Total RNA Isolation—Total RNA was prepared from two mixtures of
three different livers from 3- or 4-month-old mice by the guanidinium
thiocyanate procedure (33). The quantity and purity of the RNA was
assessed by measuring absorbance at 260 and 280 nm.
Analysis of Differential Gene Expression Using Differential Display—
Total RNA was analyzed by RT-PCR-based differential display as de-
scribed by Liang and Pardee (34). DNase-treated RNA (400 ng) was
reverse-transcribed using anchored primers D1 (5-T11GC-3) or D2
(5-T11GG-3) or D4 (5-T11CG-3) and superscript II reverse tran-
scriptase (Invitrogen). One-fortieth of the reverse transcriptase mixture
was used for the subsequent amplification by PCR with 2.5 M concen-
trations of the same D1 and D2 and D4 as 3 primers and 0.5 M
concentrations of an arbitrary 5 primer: U2 (5-TTGATCCGAG-3), 2.5
mM MgCl2, 10 M dNTPs, 1 Ci of [-
33P]dATP (PerkinElmer Life
Sciences), and 1 unit of Taq polymerase (Invitrogen) in 20 mM Tris-HCl,
pH 8.0, 50 mM KCl. The mixture was subjected to the following cycles:
1 (5 min at 94 °C, 5 min at 40 °C, 5 min at 72 °C), 39 (15 s at 95 °C,
2 min at 40 °C, 1 min at 72 °C), 1 (5 min at 72 °C). The amplified
cDNAs were separated on a 6% DNA sequencing gel. Total RNA from
two extractions of mixtures of three different tissues was used, and
duplicate RT-PCRs were performed and repeated at least twice to
ensure reproducibility.
Cloning and Sequencing of cDNA Fragments—DNA bands of interest
were cut from the sequencing gels and eluted, then reamplified by PCR
with the same primer pairs. The amplified fragments were inserted
directly into the pCR2.1 TA vector by using the TA cloning kit (Invitro-
gen) and sequenced using the T7 sequencing kit (Amersham Bio-
sciences). The sequences were compared with the GenBankTM data base
using the BLAST program.
Analysis of Differential Gene Expression Using a Mouse cDNA Ar-
ray—Radiolabeled cDNA probes were generated by reverse transcrip-
tion of total RNA (2.5 g) with Moloney murine leukemia virus reverse
transcriptase and 35 Ci of [-32P]dATP (PerkinElmer Life Sciences).
The radiolabeled cDNA probes were purified from unincorporated nu-
cleotides by column chromatography using the NucleoSpin extraction
kit (Clontech) and hybridized overnight at 68 °C to an atlas mouse
stress cDNA expression array consisting of 140 known mouse genes as
described by the manufacturer (Clontech catalog number 7749-10). The
membranes were washed four times for 30 min in 2 saline-sodium
citrate (SSC; 1 SSC  0.15 M NaCl and 0.015 M sodium citrate), 1%
SDS followed by one time for 30 min in 0.1 SSC, 0.5% SDS at 68 °C
and exposed to x-ray film (Kodak Biomax MS). The x-ray films were
scanned, and the images were analyzed using the AtlasImageTM Soft-
ware (Clontech).
Northern Blot Analysis—Samples of denatured RNA (15 g) from
each group were electrophoresed for 3 h on a 2.2 M formaldehyde, 1%
agarose gel. After a capillary transfer onto a nylon membrane (Appli-
gene Oncor), the membrane was cross-linked using a UV transillumi-
nator (Stratalinker, Appligene Oncor). The isolated cDNA fragments of
RT-PCR analysis were used as probes for verification of differential
expression by Northern blotting. cDNA-specific probes of genes in-
cluded on the cDNA array were obtained by reverse transcription of
DNA-free RNA (500 ng) from liver tissues with specific primers com-
plementary to the studied cDNA and superscript II reverse tran-
scriptase (Invitrogen) followed by PCR amplification using nested prim-
ers before labeling. Specific probes were generated by labeling the
cDNA fragments with [-32P]dCTP (PerkinElmer Life Sciences) using
the Multiprime DNA labeling system (Amersham Biosciences). After an
overnight incubation in the probe solution (ExpressHyb solution, Clon-
tech) at 68 °C, the membrane was washed 3 times for 30 min in 0.1
SSC, 0.1% SDS at 68 °C. An autoradiogram was generated by exposing
the washed membrane to film (Fuji) for overnight at 80 °C. We en-
sured that loading was equal and the RNA from the liver samples had
not been degraded by hybridization with a probe specific for mouse
SOD1 gene. Changes in steady-state mRNA levels were quantified by
densitometric scanning using Image Analysis Software and normalized
to SOD1 to correct for differences in gel loading.
Paraoxonase Enzyme Assays—PON activity toward phenyl acetate
(Sigma-Aldrich) was quantified spectrophotometrically using 50 mM
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Tris-HCl, pH 8, containing 1 mM CaCl2 and 5 mM phenyl acetate. The
reaction was monitored for 10 min at 35 °C by measuring the appear-
ance of phenol at 270 nm with the use of continuously and automated
recording spectrophotometer (PowerWaveX microplate spectrophotom-
eter of Biotek instruments with KC4 software). All rates were deter-
mined in duplicate and corrected for non-enzymatic hydrolysis (35). The
enzyme activity is expressed as A270 per min and per mg of cellular
proteins of liver.
RESULTS
Hepatic CBS Protein Production and tHcy Levels—CBS /
mice fed a standard laboratory diet died before 1 month of age.
Betaine-homocysteine methyltransferase in liver and kidney
cells can transfer a methyl group to methionine from betaine,
the oxidized form of choline, providing a secondary pathway for
homocysteine remethylation (36). Therefore, to allow us to
study adult mice (3- and 4-month-old), CBS /, CBS /, and
CBS / mice were fed standard A04 rodent chow (Usine
d’Alimentation Rationnelle) enriched in choline chloride, nec-
essary to the survival of CBS / mice. CBS / and CBS /
mice were also fed supplemented chow to avoid gene expression
modulations due to the diet.
Hepatic CBS protein production and hepatic tHcy concentra-
tions were measured. We carried out Western blotting experi-
ments using a polyclonal antibody against rat CBS (32) to
probe protein extracts from the livers of CBS /, CBS /,
and CBS / mice. Two bands, 68 and 50 kDa, were detected
(Fig. 1). The band at 50 kDa was found to be nonspecific; its
intensity did not differ significantly between the three extracts
and, thus, could serve as an internal control. The intensity of
the specific band of 68 kDa in crude liver extracts from CBS
/ mice was half that in CBS / mice; the band was absent
from extracts from CBS / mice (Fig. 1). The same results
were obtained with protein samples isolated from the brains of
CBS /, CBS /, and CBS / mice (37).
Commensurate with this difference in hepatic CBS protein
abundance, the mean hepatic concentration of tHcy in CBS
/ mice was approximately 20-fold higher than that in CBS
/ mice (tHcy concentrations were 6.44  3.86 versus 0.34 
0.14 nmol/mg of cellular protein; p  0.001 by Student’s t test
n  5 for each). In contrast, hepatic tHcy concentrations in CBS
/ mice fed a standard rodent chow enriched in choline chlo-
ride that is sufficient in folate and vitamin B6 were not signif-
icantly different from those in CBS / mice (tHcy levels were
0.43  0.15 versus 0.34  0.14 nmol/mg of cellular protein; p 
0.35 by Student’s t test n  5 for each).
Plasma tHcy concentration was also higher in CBS / mice
than in CBS / mice (205  86 versus 3.9  0.9 M; p 
0.0001 by Student’s t test n  4 for each). CBS / mice had
intermediate plasma tHcy levels 	2-fold that in CBS / mice
(tHcy levels were 9.1  2.4 versus 3.9  0.9 M; p  0.0001 by
Student’s t test n  8 for each). Plasma levels of tHcy in mice
are generally lower than those in humans; nevertheless, the
plasma tHcy concentrations resulting from partial CBS defi-
ciency in mice have been shown to be sufficient to cause endo-
thelial dysfunction (18, 21, 22). Therefore, CBS / mice and
CBS / mice may be suitable for pathophysiological study of
mild and severe HH and can be used to identify the genes
involved.
Identification by Differential Display of Transcripts Differen-
tially Expressed in Liver from CBS / and CBS /
Mice—We sought to identify genes that are differentially ex-
pressed in the liver of CBS-deficient mice. We compared liver
RNA fingerprint patterns from CBS / mice with those from
CBS / mice and CBS / mice of 3- or 4-month-old mice.
After screening using 20 primer combinations, a total of 15
cDNA fragments differentially expressed in the livers of CBS
/, CBS /, and CBS / were identified on sequencing
gels. They were isolated, cloned, and sequenced. Fig. 2A shows
the typical banding patterns for the PCR products obtained
with three different primer combinations. Band D contained
two different cDNAs (Table I). To confirm the results of differ-
ential display RT-PCR of mRNA, Northern blot analysis was
performed using probes obtained from the isolated differential
display fragments (Fig. 2B). The genes that were confirmed by
Northern blot analysis as having differential expression are
listed in Table I. Glyceraldehyde-3-phosphate dehydrogenase
(G3PDH) is widely used as an internal control in mRNA ex-
pression studies. Unexpectedly, G3PDH expression was lower
in livers from CBS / mice than in controls (Fig. 2B). The
gene encoding SOD1, an antioxidant enzyme, was expressed at
equal levels in all three groups of mice (Fig. 2B). We have also
shown no difference in hepatic SOD1 protein production (Fig.
5) and in SOD1 activity (data not shown) between CBS /,
CBS /, and CBS / mice. The mouse SOD1 probe was
therefore used as the loading control. The relative expression
levels of these genes were also quantified by densitometric
scanning of Northern blots (Table I). Three of the cDNAs cor-
responding to genes down-regulated in livers of CBS / mice
had sequences similar to those of known mouse genes (Table I):
mitochondrial cytochrome c oxidase subunit I gene (Gen-
BankTM accession number NP 008110); the gene for cyto-
chrome P450 (CYP) 3A25 (GenBankTM accession number AF
204959), a testosterone 6- hydroxylase; and the gene for ribo-
somal protein S3a (RPS3a) (GenBankTM accession number
NM_016959), a ribosomal protein that is essential for cell
growth and cellular proliferation (38, 39). One of the cDNAs
revealing up-regulation in CBS / mice was similar to the
methylthioadenosine phosphorylase gene (GenBankTM acces-
sion number AB 056100), encoding an enzyme implicated in the
salvage pathways of purines and methionine (40), and another
had sequences EST (expressed sequence tag) identical to those
in the cDNA clone 620429009 (GenBankTM accession number
AV 324910), confirming the expression of this novel transcript
of unknown function. These results demonstrate notably al-
tered mitochondrial gene expression in livers of 3- and
4-month-old CBS / mice. Mitochondrial alterations in the
liver of CBS / mice are known to generate reactive oxygen
species. Therefore, we searched for specific changes in the
expression of stress-response genes.
Identification of Differentially Expressed Stress Gene Prod-
ucts—Atlas mouse stress cDNA expression membranes (Clon-
tech) were used to identify genes modulated in response to
hepatic stress in CBS-deficient mice. The membrane used con-
tains 140 cDNA species involved in stress. The complete list of
genes is available at www.Clontech.com. Total RNA obtained
from two mixtures of three different livers of 3- or 4-month-old
CBS / and CBS / mice were used to generate 32P-labeled
cDNA probes. The probes were hybridized to the membranes.
Identical arrays were differentially screened in triplicate to
FIG. 1. CBS expression in liver of CBS / and CBS / mice.
Liver protein extracts from CBS / (/), CBS / (/), and CBS
/ (/) mice were analyzed by Western blotting, with a polyclonal
antibody against rat CBS. The band at 68 kDa was significantly less
intense than wild type in liver of CBS / mice and was undetectable
in liver of CBS / mice. The band at 50 kDa did not differ significantly
between the three extracts and was, thus, nonspecific; it could serve as
an internal control.
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eliminate false positives, and only hybridization signals of at
least 3-fold background levels were considered. Fig. 3 is an
example of one hybridization. To allow comparisons, hybridiza-
tion signals were normalized to the signals obtained from
housekeeping gene controls on the same array and to the rel-
ative decrease in expression of the G3PDH gene in CBS /
liver (Fig. 3, arrow 1, and Fig. 2B).
Computer analysis of hybridization intensities of the three
hybridizations indicated that seven known mouse genes were
differentially expressed. All of the cDNA spots indicated with
an arrow in Fig. 3 were selected for further examination. The
differential expression was evaluated by Northern blot analy-
sis; this confirmed four down-regulated and three up-regulated
CBS / mice mRNA in two independent experiments. In each
case, the relative expression levels of these genes observed on
Northern blots were consistent with the differential gene ex-
pression identified by array hybridization (Table II). We also
analyzed by Northern blotting the modulations in liver RNA of
CBS / mice. Seven comparative Northern blots were ob-
tained with the CBS /, CBS /, and CBS / livers
probed with the differentially expressed cDNAs listed in Table
II (Fig. 4). The genes with higher expression in CBS / liver
included HO-1, encoding stress-response protein that is in-
duced by a variety of agents causing oxidative stress (41),
CYP7B1 (which was also overexpressed in liver from male /
mice), encoding an oxysterol 7-hydroxylase, which plays a
crucial role in lipid and bile acid metabolism (42), and
CYP3A11, encoding a testosterone 6-hydroxylase (Fig. 4).
Genes found to be down-regulated in CBS / liver included
CYP2B9/10 (which were also underexpressed in liver from fe-
male CBS / mice), encoding testosterone 16-hydroxylases,
CYP2C29, encoding an aldehyde oxygenase, the genes for sul-
fotransferases 1,2 (STA1/2) (which were also underexpressed in
liver from female CBS / mice), two members of alcohol/
hydroxysteroid sulfotransferase gene family that catalyze the
sulfation of hydroxysteroids, and PON1, encoding a high den-
sity lipoprotein (HDL)-associated enzyme that can protect low
density lipoprotein (LDL) against oxidation by aortic wall cells
(43). CYP2B9 and CYP2B10 mRNAs are very similar in size
and nucleotide sequence. Similarly, STA1 and STA2 are very
similar. Consequently, in both cases, probes recognize both
members of the pair, which cannot be easily discriminated.
FIG. 2. Differential display analysis of mRNA from liver tissues of CBS /, CBS / mice, and CBS / mice from the same litter.
A, sequencing gel electrophoresis of cDNAs amplified by PCR (in duplicate) from liver RNAs of male (M) and female (F) CBS / (/), CBS /
(/), and CBS / (/) mice of 3 (3m)- and 4- (4m)-month-old mice. Differentially displayed fragments (arrows A, B, C, and D) were detected,
isolated, and sequenced. B, Northern blot hybridization of cDNAs A, B, C, and D and G3PDH probes with 15 g of total RNA isolated from liver
tissues of male (M) or female (F) CBS / (/), CBS / (/), and control CBS / (/) mice of 3 (3m)- and 4 (4m)-month-old mice. A
control hybridization with mouse SOD1 was used to evaluate the amount of RNA loaded. The blot is representative of two independent analyses.
A photo of the ethidium bromide staining of the same gel is shown, demonstrating that equal amounts of RNA were loaded. Ribosomal RNA bands
(28 S and 18 S) are indicated on the left. This experiment is representative of two separate experiments yielding similar results. COX1,
mitochondrial cytochrome c oxidase subunit I; CYP3A25, cytochrome P4503A25; cDNA clone, cDNA clone 620429009 3; MTAP, methylthioad-
enosine phosphorylase; kb, kilobase(s).
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Therefore, the mRNA detected on the Northern blot is referred
to as CYP2B9/10 and STA1/2, respectively (Fig. 4).
Analysis of HO-1 Protein Expression and PON1 Activity—
Expression of HO-1 was examined in CBS /, CBS /, and
CBS / liver mice by Western blotting to determine whether
HO-1 is also overexpressed at the protein level. In agreement
with increased levels of HO-1 mRNA, HO-1 protein expression
was induced in liver of CBS / mice (Fig. 5).
Activity of PON1 was also examined in liver extracts of CBS
/, CBS /, and CBS / mice. The mean hepatic activity
of PON1 in CBS / mice was not different from those in CBS
/ mice (data not shown). Commensurate with the difference
in hepatic mRNA PON1 abundance, the mean hepatic activity
of PON1 in CBS / mice was 	3-fold lower than that in CBS
/ mice (PON1 activities were 8.8  2.6 versus 24.4  4.2
A270/min/mg of cellular protein; p  0.03 by Student’s t test
n  4 for each).
To determine whether the difference in PON1 activity is due
to the loss of CBS expression or due to the resultant HH,
activity of PON1 was also examined in liver extracts of CBS
/ and CBS / fed a hyperhomocysteinemic diet. At the
time of weaning, CBS / mice and CBS / mice were
provided with drinking water that was supplemented with
0.5% L-methionine (defined as high methionine diet) (20), and
mice were studied at 3 months of age. The mean hepatic activ-
ity of PON1 in CBS / mice fed a hyperhomocysteinemic diet
was not different from those in CBS / mice fed a standard
rodent diet (data not shown), and the mean plasma concentra-
tion of tHcy was 2-fold that in CBS / mice fed a standard
rodent diet (tHcy levels were 9.3  1 versus 3.9  0.9 M; p 
0.0001 by Student’s t test n  4 for each). However, CBS /
mice fed a hyperhomocysteinemic diet have a significant de-
crease in mean hepatic activity of PON1 (PON1 activities were
13.2  1.7 versus 24.4  4.2 A270/min/mg of cellular protein;
p  0.005 by Student’s t test n  4 for each), and the mean
plasma concentration of tHcy was 2-fold that in CBS / mice
fed a hyperhomocysteinemic diet and in CBS / mice fed a
standard rodent diet (tHcy levels were 15  0.6 versus 9.2  1.8
M; p  0.0001 by Student’s t test n  4 for each). These results
show that the decrease in PON1 activity is inversely correlated
with moderate to severe HH in mice.
DISCUSSION
Severe HH, defined as plasma tHcy concentrations greater
that 30 M, is most often caused by mutations in CBS. Several
groups have investigated the cellular processes affected by HH.
They looked for genes induced in cells cultured in vitro in media
with high concentrations of Hcy. Hcy is an intermediate amino
acid formed during intracellular demethylation of methionine,
and extracellular Hcy results from cellular export of Hcy. The
plasma tHcy concentration is higher in CBS / mice than in
CBS / mice, reflecting the higher hepatic level. However,
CBS / mice have mildly elevated plasma tHcy concentra-
tions, and this does not reflect the hepatic tHcy level.
We used differential screening of mRNAs prepared from the
liver of CBS /, CBS /, and CBS / mice to provide
insight into perturbations associated with CBS deficiency and,
thus, with high hepatic tHcy concentrations. We also analyzed
by Northern blotting the modulations in the liver RNA of CBS
TABLE I
cDNA fragments corresponding to mRNAs differentially expressed in the liver of CBS / and CBS / mice
detected by differential display analysis




cDNA synthesis Primers used in PCR
Reason for
excision Northern blot
a Similar known mouse genes
GenBankTM accession numberb
A D1 (T11GC) U2 (TTGATCCGAG),
D1 (T11GC)
2 Down-regulated 3-fold only in liver
of CBS /
Cytochrome c oxidase subunit
I (COX1), NP 008110
B D4 (T11CG) U2 (TTGATCCGAG),
D4 (T11CG)
2 Down-regulated 3-fold in liver of




C D4 (T11CG) U2 (TTGATCCGAG),
D4 (T11CG)
2 Down-regulated 22-fold only in
liver of CBS /
RPS3a, NM_016959
D D2 (T11GG) U2 (TTGATCCGAG),
D2 (T11GG)





D D2 (T11GG) U2 (TTGATCCGAG),
D2 (T11GG)
1 Up-regulated 25-fold only in liver
of CBS /
cDNA clone 620429009 3, AV
324910
a After autoradiography, signal density of each RNA band, normalized to SOD1, was expressed as relative fold-change in gene expression vs.
control levels. Results represent the average of two independent hybridization experiments.
b As found by searching the GenBankTM and the EMBL databases using BLAST and FASTA.
FIG. 3. Analysis of differential stress gene expression in liver
of CBS / mice. mRNAs from CBS / and CBS / mouse liver
were studied with Atlas mouse stress cDNA expression arrays. The
images show an example of the stress membranes hybridized with
32P-labeled cDNA probes generated from total RNA isolated from livers
of CBS / (/) or CBS / (/) mice. The image intensities have
been adjusted according to the average of the relative intensities of the
housekeeping genes (first line) and the relative decrease in expression
of G3PDH in liver of CBS / (arrow 1) as shown by Northern blot
analysis in Fig. 2B. Arrows with numbers indicate increased or de-
creased intensities representative of three separate hybridization
experiments.
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/ and CBS / mice with or without the supplemented diet
with choline, and we have obtained the same results (data not
shown). Some of the modifications of expression were only
observed in the livers of CBS / mice, and others were only
observed in the livers of CBS / mice and CBS / mice.
Note that hepatic tHcy levels in CBS / mice do not differ
significantly from those in CBS / mice. We did not observe
modifications of genes in the liver of CBS / mice that were
not modified in CBS / mice.
We report altered expression of genes encoding RPS3a and
TABLE II
Identification of genes corresponding to mRNAs differentially expressed in liver of CBS / and CBS / mice as assessed by
stress cDNA expression arrays and northern blot analysis
Relative change in
gene expressiona Mouse gene name, GenBank
TM accession number Northern blot
21 Glyceraldehyde-3-phosphate dehydrogenase (G3PDH,
GAPDH), M32599
Down-regulated 5-fold only in liver of CBS /
(GAPDH)
12 HO-1; p32 protein, M33203 Up-regulated 3-fold only in liver of CBS /
(HO-1)
23 Cytochrome P450 IIB9 (clone PF26; CYP2B9); P450-16, RIP;
testosterone 16-hydroxylase  cytochrome P450 IIB10
(clone PF3/46; CYP2B10)  testosterone 16-hydroxylase
type A (16AOH-A)  testosterone 16-hydroxylase type B
(16AOH-B), M21855  M21856  M60273  M60358
Down-regulated 2-fold in liver of female CBS
/ and female CBS / (CYP2B9/10)
14 Cytochrome P450 VIIB1 (CYP7B1); oxysterol 7-hydroxylase;
HCT-1, U 36993
Up-regulated 68-fold in liver of male CBS /
and male CBS / (CYP7B1)
25 Cytochrome P450 IIC29 (CYP2C29); P450-MUT-2; aldehyde
oxygenase, D 17674
Down-regulated 33-fold only in liver of CBS /
 (CYP2C29)
16 Cytochrome P450 IIIA11 (CYP3A11); P450-UT, X60452 Up-regulated 2-fold only in liver of CBS /
(CYP3A11)
27 STA1; hydroxysteroid sulfotransferase  STA2 (STH2),
L02335 / L27121
Down-regulated 8-fold in liver of female CBS
/ and female CBS / (STA1/2)
28 PON1; serum aryldiakylphosphatase 1; aromatic esterase 1
(A-esterase 1), L40488
Down-regulated 10-fold only in liver of CBS
/ (PON1)
a Relative gene expression levels were determined by normalizing the hybridization signals to the signals obtained for the housekeeping genes
and the relative decrease in expression of G3PDH in the liver of CBS / mice.1 indicates up-regulation and2 indicates down-regulation in the
liver of CBS / and (or) CBS / mice.
b After autoradiography, signal density of each RNA band, normalized to SOD1, was expressed as relative fold-change in gene expression vs.
control levels. Results represent the average of two independent hybridization experiments.
FIG. 4. Northern blot analysis confirming the cDNA microarray results. Total RNA was isolated from liver of male (M) or female (F) CBS
/ (/), CBS / (/), CBS / (/) mice of 3 (3m)- and 4 (4m)-month-old mice. Gels were stained with ethidium bromide (ribosomal RNA
bands are indicated on the left as 28 S and 18 S). Northern blots were hybridized with 32P-labeled probes for the given gene and SOD1 for the
loading control (shown below for each). Numbers corresponding to the increased or decreased intensities shown on the arrays are indicated. The
results are representative of two experiments. CYP2C29, cytochrome P450 IIC29; CYP3A11, cytochrome P450 IIIA11; CYP7B1, cytochrome P450
VIIB1; CYP2B9/10, cytochrome P450 IIB9/10; kb, kilobase(s).
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methylthioadenosine phosphorylase, suggesting such cellular
growth and proliferation perturbations may occur in homozy-
gous CBS-deficient mice liver. The gene encoding RPS3a was
down-regulated, and it has been shown that apoptosis is in-
duced in certain cell lines by lowering constitutively high levels
of RPS3a expression using antisense RPS3a gene sequences
(44). The gene encoding methylthioadenosine phosphorylase
was up-regulated. Methylthioadenosine, the substrate of meth-
ylthioadenosine phosphorylase, is a potent inhibitor of S-ad-
enosylmethionine-dependent transmethylation reactions (40).
CBS / mice have elevated plasma levels of tHcy and a
concomitant increase in S-adenosyl-L-Hcy, a potent inhibitor of
methyltransferases, notably in liver (45). Thus, other metabolic
perturbations caused by CBS deficiency might have possible
effects upon gene expression patterns in liver of CBS / mice.
We demonstrated the presence of oxidative stress in liver of
CBS-deficient mice. The expression of many CYP was affected
in CBS / and CBS / liver cells, indicating perturbation of
the redox potential. One mitochondrial mRNA transcript (mi-
tochondrial cytochrome c oxidase subunit I) was down-regu-
lated in CBS / liver. This suggests that all mitochondrial
transcripts are down-regulated because all mitochondrial tran-
scription depends on a single promoter (46). This effect could
also be attributed to oxidative damage, which is particularly
important in the mitochondrial compartment. High concentra-
tions of Hcy on human megakaryocytic cell line cells decrease
mitochondrial gene expression in the presence of physiological
concentrations of Cu2 (14). The down-regulation of mitochon-
drial RNAs may be a general mechanism by which cells of liver
of CBS / mice protect themselves against oxidative stress.
Changes in the intracellular redox state associated with
elevated tHcy levels in liver of CBS / mice can alter the
expression of intracellular defense genes induced in response to
stressful conditions. The activity of several antioxidant en-
zymes including glutathione peroxidase was decreased in liver
of CBS / mice (47). Glutathione, which plays a key role in
the cellular defense against oxidative stress, is less abundant
in liver of CBS / than control mice (47). Approximately half
of the intracellular glutathione pool in human liver cells is
derived from Hcy via the transsulfuration pathway (48). The
Hcy-dependent transsulfuration pathway is important for
maintaining the intracellular glutathione pool, and abnormal-
ity in this pathway compromises the redox buffering capacity of
cells. Therefore, the susceptibility of hepatic tissues to oxida-
tive stress may be enhanced by CBS deficiency. We have shown
that expression of HO-1 is powerfully induced in liver of CBS
/ mice at the transcriptional and protein expression levels.
Agents that are oxidants or can generate active intermediates
lead to induction of HO-1 in cultured human skin fibroblasts
(49). Induction of HO-1 mRNA may be a result of oxidative
stress in the liver of CBS / mice, and overexpression of HO-1
protein could contribute to a cytoprotective mechanism to pre-
vent further oxidative injury in the liver.
Werstuck et al. (24) demonstrate that HH-induced endoplas-
mic reticulum stress in hepatocytes results in an enhanced
lipid biosynthesis by activation of the sterol regulatory ele-
ment-binding protein, thus leading to hepatic steatosis. CBS
/ mice fed a hyperhomocysteinemic diet have increased
hepatic cholesterol and triglyceride levels through increased
hepatic expression of genes involved in cholesterol and triglyc-
eride synthesis, uptake, and storage (24). We have also seen by
histological analysis of liver sections from CBS / mice that
hepatocytes are engorged with lipid vesicles (data not shown),
but we have not found expression modulations of genes in-
volved in hepatic metabolism of cholesterol. Even if we have not
screened all the hepatic transcripts of CBS / mice, we have
used a mouse stress cDNA expression membrane that contains
the gene encoding peroxisome proliferator-activated receptor ,
and overexpression of peroxisome proliferator-activated recep-
tor  has been associated to the development of hepatic stea-
tosis. Nevertheless, we have not found gene expression modu-
lation of peroxisome proliferator-activated receptor  in the
liver of CBS / mice.
There is growing evidence that elevated plasma levels of
tHcy are associated with an increased risk of atherosclerosis.
Several studies show that Hcy induces endothelial dysfunction
and injury in CBS / (18, 19, 21, 22) and CBS / (50) mice.
Moreover, endothelial dysfunction is believed to be an impor-
tant mechanism initiating the pathogenesis of atherosclerosis.
We have found altered expression of gene encoding PON1 con-
comitant with reduced PON1 activity in the liver of CBS /
mice but also in the liver of CBS / mice fed a hyperhomo-
cysteinemic diet, which demonstrates the importance of HH in
the PON1 activity. Most serum PON1 is synthesized in the
liver, and PON1 is a protein component of HDL. It destroys
biologically active lipids in mildly oxidized LDL, thereby pre-
venting oxidized LDL build-up when antioxidant protection is
not sufficient (43, 51). This protection is very important be-
cause oxidized LDL is highly cytotoxic to the endothelium,
promotes conversion of macrophages to foam cells, and stimu-
lates monocyte recruitment and immunological responses (52).
PON1-deficient mice, when crossed to apolipoprotein E (apoE,
a protein that mediates removal of plasma lipoproteins via the
LDL receptors and other receptors)-deficient mice and fed on a
high fat high cholesterol diet, also exhibited increased expres-
sion of genes related to oxidative stress like HO-1 and were
more susceptible to atherosclerosis than wild type from the
same litter (53). Moreover, HO-1 expression in cultured artery
wall cells is up-regulated by mildly oxidized LDL (54). There-
fore, increased and decreased levels of HO-1 and PON1, respec-
tively, in the liver of CBS / mice provide indirect evidence
that severe HH may lead to higher LDL oxidation in mice. A
recent study shows that PON1 contributes to the protective
role of HDL against the oxidative damage and against toxicity
exerted by Hcy involved in the development of atherosclerosis
(55). Moreover, mice deficient in CBS and apoE develop accel-
erated aortic atherosclerosis (56). Increased lesion formation
was observed in 1-year-old CBS //apoE / mice on regular
diet and in a diet-induced milder HH in 5-month-old CBS
//apoE / mice (56) and suggests that isolated HH is
atherogenic. We have not observed atherosclerosis lesions in
CBS / mice at 3 or 4 months of age (data not shown).
Nevertheless, mice used in our study are younger than mice
used by Wang et al. (56).
In summary, the reduced PON1 activity indicates that HH in
mice could lead to higher LDL oxidation, which may influence
the development and progression of atherosclerosis lesions.
Our work also increases our understanding of the gene path-
ways involved in the pathophysiological consequences of HH.
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